|
Volumn 274, Issue 2, 1995, Pages 678-687
|
Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 (3,4 DIMETHOXYPHENYL) N HYDROXY 2 THIAZOLECARBOXIMIDAMIDE;
6 (5,6 DIMETHOXYBENZO[B]THIEN 2 YL) 4,5 DIHYDRO 5 METHYL 3(2H) PYRIDAZINONE;
CYCLIC NUCLEOTIDE PHOSPHODIESTERASE;
HISTAMINE;
HYDROGEN PEROXIDE;
ISOPRENALINE;
LEUKOTRIENE B4;
METHACHOLINE;
MILRINONE;
ORG 20241;
PHENYLEPHRINE;
PHOSPHODIESTERASE INHIBITOR;
ROLIPRAM;
THROMBOXANE B2;
UNCLASSIFIED DRUG;
AIRWAY;
ANIMAL TISSUE;
AORTA;
ARTICLE;
ASTHMA;
BRONCHUS;
CATTLE;
DRUG POTENTIATION;
ENZYME INHIBITION;
EOSINOPHIL;
GUINEA PIG;
HEART MUSCLE REFRACTORY PERIOD;
HEART PAPILLARY MUSCLE;
HEART REPOLARIZATION;
HUMAN;
HUMAN TISSUE;
INOTROPISM;
MALE;
MUSCLE ACTION POTENTIAL;
NONHUMAN;
PRIORITY JOURNAL;
RABBIT;
SMOOTH MUSCLE CONTRACTION;
SMOOTH MUSCLE RELAXATION;
TRACHEA;
2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES;
ANIMAL;
ASTHMA;
CATTLE;
GUINEA PIGS;
HUMAN;
IN VITRO;
ISOENZYMES;
MALE;
MUSCLE, SMOOTH, VASCULAR;
PAPILLARY MUSCLES;
PHOSPHODIESTERASE INHIBITORS;
PYRROLIDINONES;
RABBITS;
ROLIPRAM;
THIAZOLES;
TRACHEA;
|
EID: 0029153656
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (22)
|
References (0)
|